Apeiron Biologics Company

Apeiron Biologics is a biotech company that focuses on the discovery and development of novel cancer immunotherapies.
Technology: Atrificial Vectors and Immune Cells
Industry: Atrificial Vectors and Immune Cells, End-to-end Drug Development
Headquarters: Vienna, Wien, Austria
Founded Date: 2005-01-01
Employees Number: 11-50
Funding Status: N/A
Investors Number: 2
Total Funding: 25000000
Estimated Revenue: $1M to $10M
Last Funding Date: 2020-05-18
Last Funding Type: Corporate Round

Visit Website
Register and Claim Ownership